bf/NASDAQ:SONN_icon.jpeg

COM:SONNETBIO

Sonnet BioTherapeutics Holdings, Inc.

  • Stock

USD

Last Close

2.89

22/11 21:00

Market Cap

2.61M

Beta: -

Volume Today

45.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '17
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
net income
-14.46M
-
-7.17M
50.43%
-4.87M
32.03%
-24.27M
398.13%
-24.98M
2.96%
-29.72M
18.96%
-18.83M
36.64%
depreciation and amortization
2.36M
-
2.28M
3.47%
2.16M
5.22%
58.31K
97.30%
95.16K
63.19%
93.26K
2.00%
75.75K
18.77%
deferred income tax
94.53K
-
-706.20K
847.08%
-702.59K
0.51%
-125.50K
-
2.63M
-
stock based compensation
-277.67K
-
-1.10M
295.21%
-1.46M
33.13%
370.06K
125.33%
1.38M
271.68%
876.37K
36.28%
248.63K
71.63%
change in working capital
277.67K
-
1.10M
295.21%
2.13M
94.03%
1.40M
34.46%
1.09M
22.18%
93.46K
91.39%
-3.12M
3,433.50%
accounts receivables
-758.10K
-
35.15K
104.64%
91.80K
161.13%
-69.27K
-
inventory
-130.61K
-
23.06K
117.66%
8.88K
61.47%
69.27K
-
accounts payables
1.17M
-
1.04M
10.91%
1.39M
33.72%
168.81K
87.85%
1.72M
921.14%
971.04K
43.67%
-2.63M
370.97%
other working capital
-277.67K
-
-1.10M
295.21%
639.02K
158.23%
1.23M
91.96%
-637.73K
151.99%
-877.58K
37.61%
-484.31K
44.81%
other non cash items
6.63M
-
4.87M
26.65%
516.23K
89.39%
6.83M
1,222.37%
623
99.99%
971.48K
155,835.31%
-2.35M
341.82%
net cash provided by operating activities
-5.36M
-
-724.43K
86.49%
-2.23M
207.23%
-15.61M
601.57%
-22.55M
44.43%
-27.69M
22.77%
-21.34M
22.92%
investments in property plant and equipment
-1.80M
-
-1.63M
9.61%
-2.39M
47.21%
-76.18K
96.82%
-3.62K
95.24%
-896.48K
24,644.05%
-443.25K
50.56%
acquisitions net
-9.02M
-
1.44M
-
purchases of investments
sales maturities of investments
500K
-
other investing activites
-169.64K
-
461.16K
371.85%
-1.49M
422.22%
net cash used for investing activites
-10.49M
-
-1.16M
88.90%
-2.44M
109.81%
-76.18K
96.88%
-3.62K
95.24%
-896.48K
24,644.05%
-443.25K
50.56%
debt repayment
-864.55K
-
-110.73K
87.19%
-20.44K
81.55%
-748
-
common stock issued
279.36K
-
280.67K
0.47%
2.78M
891.20%
19.07M
585.48%
42.85M
124.69%
1.84M
95.70%
21.01M
1,040.46%
common stock repurchased
dividends paid
other financing activites
16.86M
-
1.80M
89.32%
338.49K
81.20%
4.05M
1,095.27%
2
100.00%
2.17M
108,632,350%
849
99.96%
net cash used provided by financing activities
17.14M
-
2.08M
87.85%
2.26M
8.38%
23.01M
919.76%
42.83M
86.17%
4.01M
90.63%
21.01M
423.26%
effect of forex changes on cash
1.78K
-
-22.88K
1,383.45%
-10.90K
52.36%
net change in cash
1.28M
-
169.92K
86.75%
30.23K
82.21%
7.31M
24,092.13%
20.27M
177.16%
-24.57M
221.20%
-778.62K
96.83%
cash at beginning of period
245.83K
-
268.57K
9.25%
5.42K
97.98%
35.65K
557.93%
7.35M
20,515.10%
27.62M
275.82%
3.05M
88.95%
cash at end of period
1.53M
-
438.49K
71.30%
35.65K
91.87%
7.35M
20,515.10%
27.62M
275.82%
3.05M
88.95%
2.27M
25.50%
operating cash flow
-5.36M
-
-724.43K
86.49%
-2.23M
207.23%
-15.61M
601.57%
-22.55M
44.43%
-27.69M
22.77%
-21.34M
22.92%
capital expenditure
-1.80M
-
-1.63M
9.61%
-2.39M
47.21%
-76.18K
96.82%
-3.62K
95.24%
-896.48K
24,644.05%
-443.25K
50.56%
free cash flow
-7.16M
-
-2.35M
67.19%
-4.62M
96.54%
-15.69M
239.74%
-22.56M
43.75%
-28.58M
26.72%
-21.79M
23.79%

All numbers in USD (except ratios and percentages)